Cosmos Health (COSM) announced its entry into the U.S. market and the launch of U.S.-based manufacturing through a strategic ...

DolCas Biotech LLC is a U.S.-based developer and marketer of branded, science-backed nutraceutical ingredients, founded in 2007 as an extension of Orcas Naturals founded in 1993.

DolCas Biotech, a developer and manufacturer of clinically studied nutraceutical ingredients, will produce Cosmos Health’s products at its U.S. facilities.

About DolCas Biotech LLC DolCas Biotech LLC is a U.S.-based developer and marketer of branded, science-backed nutraceutical ingredients, founded in 2007 as an extension of Orcas Naturals founded in ...

DolCas Biotech LLC is a U.S.-based developer and marketer of branded, science-backed nutraceutical ingredients, founded in 2007 as an extension of Orcas Naturals founded in 1993. Its portfolio ...

About DolCas Biotech LLC DolCas Biotech LLC is a U.S.-based developer and marketer of branded, science-backed nutraceutical ingredients, founded in 2007 as an extension of Orcas Naturals founded ...

Biotech firms are gaining major traction in 2025 due to the global pandemic. Take a look at some of the key features of biotech stocks before investing.

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19.If these times have anything to say about it ...

Tucson-based biotech firm HTG Molecular Diagnostics has filed for Chapter 11 bankruptcy, with plans to operate as it works out a plan to pay its debts.

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients ...

Defining success for early-stage, small biotech trials can be crucial for the success of Phase 1 and Phase 2 clinical trials. Learn more about the key metrics and considerations in this process.